HCWB - HCW Biologics Inc.
0.6201
-0.010 -1.580%
Share volume: 92,499
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.63
-0.01
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 03-28-2025 | 05-15-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 30.428 M | 26.820 M | 26.556 M | 30.237 M | 26.285 M | 25.446 M | |
| Current Assets | 6.209 M | 2.386 M | 2.094 M | 5.698 M | 1.895 M | 1.589 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 187.267 K | 164.607 K | 88.131 K | 113.528 K | 443.311 K | 250.340 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 1.154 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.084 M | 1.161 M | 998.221 K | 4.675 M | 1.108 M | 1.097 M | |
| Total Non-current Assets | 1.600 M | 1.600 M | 1.600 M | 1.600 M | 1.600 M | 1.326 M | |
| Property Plant Equipment | 22.591 M | 22.806 M | 22.834 M | 22.910 M | 22.762 M | 22.502 M | |
| Other Assets | 1.628 M | 1.628 M | 1.628 M | 1.628 M | 1.628 M | 1.355 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 30.428 M | 26.820 M | 26.556 M | 30.237 M | 26.285 M | 25.446 M | |
| Total liabilities | 21.687 M | 33.120 M | 36.526 M | 37.007 M | 34.847 M | 27.553 M | |
| Total current liabilities | 13.413 M | 23.219 M | 30.063 M | 29.629 M | 27.142 M | 26.860 M | |
| Accounts Payable | 13.413 M | 23.219 M | 23.723 M | 23.314 M | 20.908 M | 20.053 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 692.531 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 8.274 M | 9.901 M | 6.463 M | 7.378 M | 7.705 M | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 692.531 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 8.741 M | -6.300 M | -9.970 M | -6.770 M | -8.562 M | -2.107 M | |
| Common stock | 86.741 M | 86.981 M | 87.213 M | 93.786 M | 94.191 M | 107.128 M | |
| Retained earnings | -78.000 M | -93.281 M | -97.183 M | -100.556 M | -102.753 M | -109.235 M |